Dudum Andrew's Form 4 filing
Hims & Hers Health, Inc.HIMS · filed Oct 20, 2025
- Accession no.
- 0001773751-25-000342
- Filed
- Oct 20, 2025
- Trade date
- Oct 16, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 11 non-derivative transactions and 2 derivative transactions. Open-market sales total $11.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dudum AndrewCIK 0001837796 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2025 | Class A Common Stock | SSaleDisposed | −2,792 | $62.65F2 | −$174,918.8 | 92,523 | Direct | |
| Oct 16, 2025 | Class A Common Stock | SSaleDisposed | −39,111 | $62.70F3 | −$2,452,259.7 | 55,947 | Indirect | |
| Oct 16, 2025 | Class A Common Stock | SSaleDisposed | −8,423 | $63.46F4 | −$534,523.58 | 47,524 | Indirect | |
| Oct 16, 2025 | Class A Common Stock | MOption exerciseAcquired | +17,001 | $2.43 | +$41,312.43 | 109,524 | Direct | |
| Oct 16, 2025 | Class A Common Stock | SSaleDisposed | −17,001 | $62.69F5 | −$1,065,792.69 | 92,523 | Direct | |
| Oct 16, 2025 | Class A Common Stock | MOption exerciseAcquired | +108,334 | $2.43 | +$263,251.62 | 200,857 | Direct | |
| Oct 16, 2025 | Class A Common Stock | SSaleDisposed | −39,531 | $62.71F6 | −$2,478,989.01 | 161,326 | Direct | |
| Oct 16, 2025 | Class A Common Stock | SSaleDisposed | −10,469 | $63.49F7 | −$664,676.81 | 150,857 | Direct | |
| Oct 16, 2025 | Class A Common Stock | SSaleDisposed | −39,332 | $62.70F8 | −$2,466,116.4 | 111,525 | Direct | |
| Oct 16, 2025 | Class A Common Stock | SSaleDisposed | −2,335 | $63.39F9 | −$148,015.65 | 109,190 | Direct | |
| Oct 16, 2025 | Class A Common Stock | SSaleDisposed | −16,667 | $62.70F5 | −$1,045,020.9 | 92,523 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2025 | Class A Common Stock | MOption exerciseDisposed | −17,001 | $0.00 | $0 | 17,005 | Direct | |
| Oct 16, 2025 | Class A Common Stock | MOption exerciseDisposed | −108,334 | $0.00 | $0 | 431,395 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.50 - $62.87. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.215 - $63.13. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $63.31 - $63.59. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.25 - $62.94. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 2 transactions in Table I.
- F6
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.22 - $63.18. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $63.25 - $63.63. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.22 - $63.20. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F9
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $63.26 - $63.47. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.